Wuxi Biologics blacklisted
Chinese pharmaceutical firm: $9.9 billion stocks vanish after blacklisted by US
On Feb. 9, Chinese pharmaceutical firm Wuxi Biologics, whose Shanghai subsidiary made its name to the Unverified Entity List (UVL), saw 25% of its stock evaporate, losing $9.9 billion off its market value. The sudden decrease came after its Shanghai subsidiary appeared on the U.S.’s UVL, announced on Feb. 8. Trading ...
End of content
No more pages to load